-
Je něco špatně v tomto záznamu ?
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients
B. Weinbergerova, J. Mayer, T. Kabut, S. Hrabovsky, J. Prochazkova, Z. Kral, V. Herout, R. Pacasova, L. Zdrazilova-Dubska, P. Husa, P. Bednar, D. Ruzek, M. Lengerova
Jazyk angličtina Země Velká Británie
Typ dokumentu klinické zkoušky, dopisy
PubMed
34396566
DOI
10.1002/hon.2908
Knihovny.cz E-zdroje
- MeSH
- adenosinmonofosfát analogy a deriváty terapeutické užití MeSH
- alanin analogy a deriváty terapeutické užití MeSH
- antivirové látky terapeutické užití MeSH
- COVID-19 komplikace terapie virologie MeSH
- dospělí MeSH
- farmakoterapie COVID-19 MeSH
- hematologické nádory epidemiologie prevence a kontrola virologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- pasivní imunizace MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- SARS-CoV-2 izolace a purifikace MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- dopisy MeSH
- klinické zkoušky MeSH
- Geografické názvy
- Česká republika MeSH
Department of Clinical Microbiology and Immunology University Hospital Brno Brno Czech Republic
Department of Infectious Diseases Masaryk University Brno Czech Republic
Department of Infectious Diseases University Hospital Brno Brno Czech Republic
Department of Internal Medicine Hematology and Oncology Masaryk University Brno Czech Republic
Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Department of Respiratory Diseases Masaryk University Brno Czech Republic
Department of Respiratory Diseases University Hospital Brno Brno Czech Republic
Faculty of Science University of South Bohemia Ceske Budejovice Czech Republic
Transfusion and Tissue Department Masaryk University Brno Czech Republic
Transfusion and Tissue Department University Hospital Brno Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003098
- 003
- CZ-PrNML
- 005
- 20230815094316.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/hon.2908 $2 doi
- 035 __
- $a (PubMed)34396566
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Weinbergerova, Barbora $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 245 10
- $a Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients / $c B. Weinbergerova, J. Mayer, T. Kabut, S. Hrabovsky, J. Prochazkova, Z. Kral, V. Herout, R. Pacasova, L. Zdrazilova-Dubska, P. Husa, P. Bednar, D. Ruzek, M. Lengerova
- 650 _2
- $a adenosinmonofosfát $x analogy a deriváty $x terapeutické užití $7 D000249
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a alanin $x analogy a deriváty $x terapeutické užití $7 D000409
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a COVID-19 $x komplikace $x terapie $x virologie $7 D000086382
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a hematologické nádory $x epidemiologie $x prevence a kontrola $x virologie $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pasivní imunizace $7 D007116
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a SARS-CoV-2 $x izolace a purifikace $7 D000086402
- 650 _2
- $a farmakoterapie COVID-19 $7 D000093485
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Mayer, Jiri $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Kabut, Tomas $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Hrabovsky, Stepan $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Prochazkova, Jirina $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Kral, Zdenek $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Herout, Vladimir $u Department of Respiratory Diseases, Masaryk University, Brno, Czech Republic $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Pacasova, Rita $u Transfusion and Tissue Department, Masaryk University, Brno, Czech Republic $u Transfusion and Tissue Department, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Zdrazilova-Dubska, Lenka $u Department of Clinical Microbiology and Immunology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Husa, Petr $u Department of Infectious Diseases, Masaryk University, Brno, Czech Republic $u Department of Infectious Diseases, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Bednar, Petr $u Veterinary Research Institute, Brno, Czech Republic $u Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic
- 700 1_
- $a Růžek, Daniel, $d 1981- $u Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $7 stk2008441707
- 700 1_
- $a Lengerova, Martina $u Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 773 0_
- $w MED00002019 $t Hematological oncology $x 1099-1069 $g Roč. 39, č. 5 (2021), s. 715-720
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34396566 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20230815094313 $b ABA008
- 999 __
- $a ok $b bmc $g 1750765 $s 1154247
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 39 $c 5 $d 715-720 $e 20210816 $i 1099-1069 $m Hematological oncology $n Hematol Oncol $x MED00002019
- LZP __
- $a Pubmed-20220113